173 related articles for article (PubMed ID: 38931860)
1. The Different Strategies for the Radiolabeling of [
Gao J; Li M; Yin J; Liu M; Wang H; Du J; Li J
Pharmaceutics; 2024 May; 16(6):. PubMed ID: 38931860
[TBL] [Abstract][Full Text] [Related]
2. Advances in the Chemistry of Astatine and Implications for the Development of Radiopharmaceuticals.
Guérard F; Maingueneau C; Liu L; Eychenne R; Gestin JF; Montavon G; Galland N
Acc Chem Res; 2021 Aug; ():. PubMed ID: 34350753
[TBL] [Abstract][Full Text] [Related]
3. Radioiodinated and astatinated NHC rhodium complexes: synthesis.
Rajerison H; Guérard F; Mougin-Degraef M; Bourgeois M; Da Silva I; Chérel M; Barbet J; Faivre-Chauvet A; Gestin JF
Nucl Med Biol; 2014 May; 41 Suppl():e23-9. PubMed ID: 24661351
[TBL] [Abstract][Full Text] [Related]
4. Astatine.
Meyer GJ
J Labelled Comp Radiopharm; 2018 Mar; 61(3):154-164. PubMed ID: 29080397
[TBL] [Abstract][Full Text] [Related]
5. Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapy.
Guérard F; Gestin JF; Brechbiel MW
Cancer Biother Radiopharm; 2013 Feb; 28(1):1-20. PubMed ID: 23075373
[TBL] [Abstract][Full Text] [Related]
6. Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.
Aneheim E; Albertsson P; Bäck T; Jensen H; Palm S; Lindegren S
Sci Rep; 2015 Jul; 5():12025. PubMed ID: 26169786
[TBL] [Abstract][Full Text] [Related]
7. Astatine-211 Radiopharmaceuticals; Status, Trends, and the Future.
Rabiei M; Asadi M; Yousefnia H
Curr Radiopharm; 2024; 17(1):7-13. PubMed ID: 37937552
[TBL] [Abstract][Full Text] [Related]
8. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
9. Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies.
Aneheim E; Halleröd J; Albertsson P; Jensen H; Holgersson S; Lindegren S
Cancer Biother Radiopharm; 2015 Feb; 30(1):41-5. PubMed ID: 25588020
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio-Crosslinking.
Denk C; Wilkovitsch M; Aneheim E; Herth MM; Jensen H; Lindegren S; Mikula H
Chempluschem; 2019 Jul; 84(7):775-778. PubMed ID: 31681526
[TBL] [Abstract][Full Text] [Related]
11. Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure.
Lindegren S; Albertsson P; Bäck T; Jensen H; Palm S; Aneheim E
Cancer Biother Radiopharm; 2020 Aug; 35(6):425-436. PubMed ID: 32077749
[TBL] [Abstract][Full Text] [Related]
12.
Maingueneau C; Berdal M; Eychenne R; Gaschet J; Chérel M; Gestin JF; Guérard F
Chemistry; 2022 Feb; 28(11):e202104169. PubMed ID: 34965315
[TBL] [Abstract][Full Text] [Related]
13. Targeted Alpha Therapy of Glioma Using
Liu W; Ma H; Liang R; Chen X; Li H; Lan T; Yang J; Liao J; Qin Z; Yang Y; Liu N; Li F
Mol Pharm; 2022 Sep; 19(9):3206-3216. PubMed ID: 35993583
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates.
Aneheim E; Gustafsson A; Albertsson P; Bäck T; Jensen H; Palm S; Svedhem S; Lindegren S
Bioconjug Chem; 2016 Mar; 27(3):688-97. PubMed ID: 26791409
[TBL] [Abstract][Full Text] [Related]
15. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601
[TBL] [Abstract][Full Text] [Related]
16. Astatine Radiopharmaceuticals: Prospects and Problems.
Vaidyanathan G; Zalutsky MR
Curr Radiopharm; 2008 Sep; 1(3):177. PubMed ID: 20150978
[TBL] [Abstract][Full Text] [Related]
17. Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211.
Timperanza C; Jensen H; Bäck T; Lindegren S; Aneheim E
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111352
[TBL] [Abstract][Full Text] [Related]
18. Development and Preclinical Evaluation of [
El Fakiri M; Ayada N; Müller M; Hvass L; Gamzov TH; Clausen AS; Geis NM; Steinacker N; Hansson E; Lindegren S; Aneheim E; Jensen H; Eder AC; Jensen AI; Poulie CBM; Kjaer A; Eder M; Herth MM
J Nucl Med; 2024 Apr; 65(4):593-599. PubMed ID: 38423784
[TBL] [Abstract][Full Text] [Related]
19. The Past, Current Studies and Future of Organometallic 99mTc(CO)3 Labeled Peptides and Proteins.
Piramoon M; Hosseinimehr SJ
Curr Pharm Des; 2016; 22(31):4854-4867. PubMed ID: 27339431
[TBL] [Abstract][Full Text] [Related]
20. Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.
Wilbur DS
Curr Radiopharm; 2011 Jul; 4(3):214-47. PubMed ID: 22201710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
